Malignant
pleural mesothelioma (UMM) is a rare lung disease, and aggressive,
which is closely linked to the previous exposure to asbestos fibers. Difficult
to diagnose the disease and resistance to conventional treatment
options since then, for the first time as a separate type of lung
cancer.
Asbestos
was widely used in the industry for decades, mesothelioma has a latency
period is too long-can take up to 50 years in its victims. Many cases are just starting to appear among those who worked in those industries. This is why the number of cases and is expected to continue to increase around the world for years to come from 30 to 40.
Doctors around the world are putting increasing energy and dollars for research to find better treatments for mesothelioma. Recent
study has focused on several new indicators (natural substances within
the body and regulations) which have proved useful in helping to
diagnose a malignant tumor. Officials from the
European Organization for research and treatment of cancer (competition)
and the Faculty of the Department of Oncology in General Hospital in
Marseille, France, banded together to report on the current status of
scientific information for malignant pleural mesothelioma.
There is a lot of information about diagnosing the disease once symptoms have begun. Mesothelioma, such as lung cancers, unfortunately often not suspected at later stages when symptoms become more severe. At this point, the doctors are less able to deal with it in ways that may extend the life of the patient. The report says that the more valuable for helping patients (early) predictive biomarkers. Treatment
at an early stage so far was more effective in prolonging survival
times, if not change the long-term prospects for this devastating
disease.
The authors urge researchers start doing more widely in order to validate the value of various biomarkers. They
propose that research efforts focused on finding biomarkers that will
predict how well chemotherapy will work with mesothelioma. They
urge that the researchers, rather than investigate the theoretical
ideas, should start doing clinical trials that focus on translating
information into practical applications that will make a difference to
patients.
If you have Mesothelioma, you live with the devastation of losing your life, or a loved one. It may be useful to see if you can become a victim to this disease because of corporate misconduct. Many
employers intentionally concealed their knowledge of the risks of
exposure to asbestos fibers from workers who lived and breathed every
day of their careers. And because it can lead to a
very small dose of asbestos Mesothelioma or asbestosis, asbestos
workers ' families may also be at risk. Asbestos dust brought home on the clothing can be just as deadly to family members who breathed it.
Please
visit our website for mesothelioma information and resource information
and support to obtain information about your legal rights
0 Comments:
Post a Comment